CRL

Charles River Laboratories International, Inc. | Cotação de Ações

Última atualização19/09/2025, 17:00:02

PreçoUS$ 155,39

Variação (dia)-US$ 1,60 (-1.02%)▼

Min. 52 SemanasUS$ 91,86

Máx. 52 SemanasUS$ 230,02

Capitalização de mercado--

Endereço: 251 Ballardvale Street, Wilmington, MA, 01887

Telefone: 781 222 6000

Funcionários: 18.700

Charles River Laboratories InteCRL

US$ 155,39

- 1,61%

19/09/2025 17:00:02

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 155,39

Valor de mercado--

AberturaUS$ 153,05

Preço máximoUS$ 157,26

Preço mínimoUS$ 153,21

VolumeUS$ 1,3 mi

Fechamento anteriorUS$ 156,99

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Ações relacionadas

Bio-Techne Corporation

TECH ▼1.77% | US$ 74,68

IQVIA Holdings Inc.

IQV ▼2.56% | US$ 204,44

The Cooper Companies, Inc.

COO ▼1.14% | US$ 98,31

Bio-Rad Laboratories, Inc.

BIO ▲11.05% | US$ 369,92

West Pharmaceutical Services, Inc.

WST ▲0.41% | US$ 345,48

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.

Acesse a Documentação para uma compreensão detalhada da nossa plataforma

Explore a Documentação para uma compreensão detalhada de como utilizar efetivamente nossa plataforma para análise de investimentos. Oferecemos recursos abrangentes para orientar investidores, desde iniciantes até experientes, na navegação por nossa plataforma.

Encontre respostas para suas dúvidas sobre investimentos em nossa seção de Perguntas Frequentes (FAQ)

Acesse a seção de Perguntas Frequentes da brapi para esclarecer dúvidas sobre investimentos. Nossa FAQ fornece informações concisas, abordando tópicos relevantes para investidores, contribuindo para uma compreensão mais clara do mercado financeiro.